Sepsis Device Enters Pivotal 350-Patient Trial by Removing DNA Immune Traps From Blood
· techtimes.com · popularity 20/100 · 0 similar stories today · Medicine & Clinical Health (Health & Life Sciences)
Read the original at techtimes.com →
Summary
Santersus launches NUC-CAP: a 350-patient pivotal trial of a sepsis device that selectively removes the DNA immune traps driving organ failure.
Found in: Tech Times. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 6.